These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17893966)

  • 1. Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus.
    Mangini AJ; Lafyatis R; Van Seventer JM
    Ann N Y Acad Sci; 2007 Jun; 1108():11-23. PubMed ID: 17893966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC.
    Meyers JA; Mangini AJ; Nagai T; Roff CF; Sehy D; van Seventer GA; van Seventer JM
    Cytokine; 2006 Sep; 35(5-6):235-46. PubMed ID: 17052915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interferons in SLE.
    Bengtsson AA; Rönnblom L
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):415-428. PubMed ID: 29224681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon in systemic lupus erythematosus.
    Crow MK
    Curr Top Microbiol Immunol; 2007; 316():359-86. PubMed ID: 17969456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus: all roads lead to type I interferons.
    Pascual V; Farkas L; Banchereau J
    Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interferons (IFNs) in the differentiation of T peripheral helper (Tph) cells.
    Tanemura S; Seki N; Tsujimoto H; Saito S; Kikuchi J; Sugahara K; Yoshimoto K; Suzuki K; Kaneko Y; Chiba K; Takeuchi T
    Int Immunol; 2022 Sep; 34(10):533-544. PubMed ID: 35780437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cause and consequences of the activated type I interferon system in SLE.
    Eloranta ML; Rönnblom L
    J Mol Med (Berl); 2016 Oct; 94(10):1103-1110. PubMed ID: 27094810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation.
    Nagai T; Devergne O; Mueller TF; Perkins DL; van Seventer JM; van Seventer GA
    J Immunol; 2003 Nov; 171(10):5233-43. PubMed ID: 14607924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded circulating peripheral helper T cells in systemic lupus erythematosus: association with disease activity and B cell differentiation.
    Makiyama A; Chiba A; Noto D; Murayama G; Yamaji K; Tamura N; Miyake S
    Rheumatology (Oxford); 2019 Oct; 58(10):1861-1869. PubMed ID: 30879065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential T Cell-Intrinsic Regulatory Roles for IRF5 via Cytokine Modulation in T Helper Subset Differentiation and Function.
    Brune Z; Rice MR; Barnes BJ
    Front Immunol; 2020; 11():1143. PubMed ID: 32582209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
    Banchereau J; Pascual V
    Immunity; 2006 Sep; 25(3):383-92. PubMed ID: 16979570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
    Chyuan IT; Tzeng HT; Chen JY
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside.
    Sim TM; Ong SJ; Mak A; Tay SH
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The innate immune system in SLE: type I interferons and dendritic cells.
    Rönnblom L; Pascual V
    Lupus; 2008 May; 17(5):394-9. PubMed ID: 18490415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
    Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I IFN Drives Experimental Systemic Lupus Erythematosus by Distinct Mechanisms in CD4 T Cells and B Cells.
    Klarquist J; Cantrell R; Lehn MA; Lampe K; Hennies CM; Hoebe K; Janssen EM
    Immunohorizons; 2020 Mar; 4(3):140-152. PubMed ID: 32161059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
    Luo S; Wang Y; Zhao M; Lu Q
    Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.
    Wong CK; Lit LC; Tam LS; Li EK; Wong PT; Lam CW
    Clin Immunol; 2008 Jun; 127(3):385-93. PubMed ID: 18373953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
    Gallucci S; Meka S; Gamero AM
    Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
    Reininger L; Santiago ML; Takahashi S; Fossati L; Izui S
    Ann Med Interne (Paris); 1996; 147(7):467-71. PubMed ID: 9092356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.